tykhr
sign in
free sign up
Lineage Cell Therapeutics Inc
Biotechnology
Healthcare
LCTX
228 M shares
NYSE MKT US
traded
23 Sep 2025
listed
no
open
1.62
52 week high
1.62
high
1.64
52 week low
0.00
low
1.55
growth
18.66 %
previous Close
1.62
P/E ratio
market cap
306 M
div yield
0
usd
Jun 2025
qoq
revenue
2.77 M
84.09 %
net incoming
-30.46 M
-636.02 %
eps
0.00 %
-550.00 %
eps surprise
-333.33 %
net profit margin
-1101.77 %
-826.00 %
operating incoming
-19.78 M
-204.07 %
net change in cash
-5.57 M
-380.03 %
cash on hand
42.27 M
-11.73 %
cost of revenue
39.00 K
8.33 %
top